Patent Ductus Arteriosus. By Dr. Hanan Zekri Khaled Lecturer of pediatrics Pediatric cardiology. Patent Ductus Arteriosus. Patent Ductus Arteriosus. Patent Ductus Arteriosus.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Patent Ductus Arteriosus
By Dr. Hanan Zekri Khaled
Lecturer of pediatrics
●The ductus arteriosus in the fetus is an important conduit that allows deoxygenated blood to bypass the collapsed lungs and enter the placenta through the descending aorta and umbilical arteries.
● The placenta acts as an oxygenator and returns oxygen rich blood through the umbilical vein and ductus venosus to the fetal heart.
● The placenta produces prostaglandins, which maintain prenatal patency of the ductus and, in early gestation, inhibit the ability of the ductus to contract in response to oxygen.
● The ductus arteriosus itself also produces prostaglandins and nitric oxide-like vasodilators.
● During the postnatal period, final closure of the ductus arteriosus results from increased production of local vasoconstrictors (like endothelin) in response to higher arterial oxygen, removal of placental prostaglandin and a decrease in the number of prostaglandin E2 receptors in the ductal wall.
Mehta SK, Younoszai A, Pietz J, Achanti BP. Pharmacological closure of the patent ductus arteriosus.Images Paediatr Cardiol 2003;14:1-15